Jan 20, 2020

TAVR: Raising the Bar to Achieve Good Outcomes

The FDA approved two types of devices for transcatheter aortic valve replacement (TAVR) after determining they were better than standard therapy for inoperable patients and an alternative to open surgery in high-risk patients. Nonetheless, this generally elderly patient population poses challenges and there are still potential missteps that could derail TAVR. Patient selection tools, 3D imaging...

Proceed to the page: http://linkis.com/40Coq

Similar Articles Added Earlier

Similar Articles Added Today

Latest Links Processed